All posts by imreal

Achieving Successful Cell Therapy Outcomes through Integrated Expertise, Upcoming Webinar Hosted by Xtalks


Successful preclinical to clinical transition requires careful planning with the aim of avoiding mistakes and surmounting barriers common to the development and operation of cell therapy trials.

As the cell therapy research and development landscape continues to advance, so do the complexities and challenges associated with clinical trials. Conducting cellular therapy trials presents a unique set of challenges, especially in early phase development. Successful preclinical to clinical transition requires careful planning with the aim of avoiding mistakes and surmounting barriers common to the development and operation of cell therapy trials.

In this webinar, Medpace medical, operational and regulatory experts will analyze previous cell therapy case studies and draw on their 30+ years of integrated, global experience to examine strategies to successfully manage complex cell therapy trials and increase the probability of clinical and regulatory success.

Register to learn how drug sponsors in the pharma and biotech industry can overcome common challenges associated with complex cell therapy trials through medical, regulatory and operational considerations, including engaging an experienced and full-service clinical research partner with cross-functional expertise.

Join experts from Medpace, Ann Woolfrey, MD, Vice-President, Medical Department; Lauren Holton, MSN, APRN, FNP-BCACP, Advanced Clinical Practitioner; Jeffrey Vassallo, PhD, Senior Director of Clinical Trial Management; and Jan Ohotski, PhD, Principal Regulatory Submissions Technical Advisor, for the live webinar on Thursday, October 20, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Achieving Successful Cell Therapy Outcomes through Integrated Expertise.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Caring Transitions of Round Rock Brings Much-Needed Services to Growing City


Monica Martinez owns Caring Transitions in Round Rock, Texas.

“At Caring Transitions, we will give families the space to grieve by handling the packing, moving, and selling of their loved one’s personal belongings.”

Caring Transitions, the leader in senior relocation and transition services, continues to expand its compassionate reach across the nation with its latest location. Caring Transitions of Round Rock is owned and operated by Monica Martinez. Martinez is committed to helping seniors downsize or declutter their homes.

Caring Transitions is a franchise designed to minimize stress by utilizing specially trained professionals to oversee every detail of a senior’s transition with compassion, including decluttering, organizing, packing, move management, unpacking, resettling, and cleanouts. The company also manages both in-home and online estate sales. The online estate sales are hosted on CTBIDS, the brand’s widely popular auction platform, which can support its clients in liquidating unique and everyday treasures that many cherish.

Martinez decided to pursue business ownership in the senior-care industry after her father passed away four years ago. At Caring Transitions, Martinez wants to offer a stress-free experience for families who lost their loved ones and need help sorting through their belongings.

“The heaviness in one’s heart to lose a loved one and then take care of their estate is insurmountable,” said Caring Transitions franchisee Monica Martinez. “At Caring Transitions, we will give families the space to grieve by handling the packing, moving, and selling of their loved one’s personal belongings.”

While Caring Transitions specializes in helping seniors move to the next phase of their life, the company can help anyone downsize, right-size, or just move efficiently. As a long-term resident of Round Rock, Martinez believes there is a need for Caring Transitions’ services in the community. She is thrilled to operate her business alongside her son, sister, and sister-in-law.

“There is an overwhelming demand for senior services in Round Rock,” said Ray Fabik, president of Caring Transitions. “We look forward to seeing Martinez thrive as she provides compassionate care and support to her clients.”

To learn more about Caring Transitions, visit https://www.caringtransitions.com/


For more about franchising opportunities with Caring Transitions, visit https://www.caringtransitionsfranchise.com/.

About Caring Transitions

Caring Transitions, founded in 2006, is the most trusted and experienced national franchise specializing in senior relocation and transition services. With more than 250 locations throughout the United States, all owned and operated by Certified Relocation and Transition Specialists, Caring Transitions provides clients with supportive moves, auctions, right-sizing, and transitions. This includes expert advice plus a well-executed transition plan beginning with the initial sorting of personal belongings through packing, unpacking, resettling, and selling of items to the final clearing and cleaning of the property.

For more information, visit http://www.caringtransitions.com or visit us on Facebook.

Share article on social media or email:

Shriners Children’s Opens Build-A-Bear Foundation Buddy Rooms at Locations throughout North America


patient with stuffed animal in hospital bed.

Patient finds comfort with her new furry friend from the new Build-A-Bear Foundation Buddy Room at Shriners Children’s Greenville.

“The bears are often a patient’s comfort item during surgery day. Comfort items are important for children of all ages to soothe and provide a sense of safety. The Build-A-Bear experience is a highlight for many patients.”

Shriners Children’s and Build-A-Bear Foundation have joined forces to offer a one-of-a-kind experience to the patients at Shriners Children’s, helping to provide hope and healing to children receiving care.

Build-A-Bear Foundation Buddy Rooms will be available at Shriners Children’s locations throughout North America for patients and families to pick out a complimentary furry friend and accessories. In an effort to make a positive impact on patient visits, Build-A-Bear Foundation is donating up to 5,000 furry friends to Shriners Children’s annually, along with an annual monetary donation. Supporters can also donate furry friends, clothes and accessories towards the Build-A-Bear Foundation Buddy Room of their choice.

“Build-A-Bear serves as an emotional anchor for our patients in a couple of important ways,” said Melissa Owen, child life specialist at Shriners Children’s Greenville. “Not only does it provide them with a way to creatively express themselves through the choice of a bear or outfit, the bears are often a patient’s comfort item during surgery day. Comfort items are important for children of all ages to soothe and provide a sense of safety. The Build-A-Bear experience is a highlight for many patients.”

Shriners Children’s is a special, one-of-a-kind healthcare system with a reputation for finding answers, and giving families hope for their child’s future. Since opening their first hospital in 1922, Shriners Children’s has made it their mission to improve the lives of children, regardless of a families’ ability to pay or insurance status.

Over the last century, Shriners Children’s has become one of the largest pediatric sub-specialty healthcare systems in the world, and treated more than 1.5 million children from more than 170 countries. Today, their multiple locations in the United States, Canada and Mexico provide advanced care for children with a range of orthopedic issues, as well as care for burn injuries, craniofacial conditions, spine care and spinal cord injuries, colorectal and gastrointestinal care, and sports medicine. Throughout its long and storied history, Shriners Children’s commitment to change lives hasn’t changed, but has only strengthened, and they are looking forward to the next 100 years of caring for children around the world.

“We are honored to partner with Shriners Children’s to bring the fun of Build-A-Bear to children and families receiving care across North America,” said Voin Todorovic, Build-A-Bear Foundation President. “We believe in the power of hugs and know a new furry friend can bring comfort and a smile during challenging times. Our hope is that Build-A-Bear Foundation Buddy Rooms add a little more heart to the days of every patient by allowing them to get a special Build-A-Bear furry friend during their visit.”

Since 1997, Build-A-Bear has been adding a little more heart to life for children and families around the world. GIVE is one of Build-A-Bear’s core values and has been a key element of the brand throughout its history. Today, their giving programs come to life through Build-A-Bear Foundation, which has contributed more than $22 million and 1.5 million furry friends to charitable organizations around the world.

To learn more about how to donate a furry friend to a Shriners Children’s Build-A-Bear Foundation Buddy Room, visit lovetotherescue.org/build-a-bear-foundation-buddy-room.

About Shriners Children’s

Shriners Children’s is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our multiple locations in the United States, Canada and Mexico provide advanced care for children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care is provided regardless of the families’ ability to pay. Shriners Children’s has treated more than 1.5 million children from more than 170 countries over the last 100 years.

For more information on the care provided by Shriners Children’s, go to shrinerschildrens.org

Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law.

About Build-A-Bear Foundation

Build-A-Bear Foundation adds a little more heart to life by sharing hugs, inspiring creativity, and supporting those in need. A 501(c)3 organization, Build-A-Bear Foundation’s core focus is to support children’s literacy programs as a path to social and educational equity. Build-A-Bear Foundation also provides financial and furry friend donations to organizations that support children’s health and wellness, disaster relief, and families in need of essential supplies. Since 1997, Build-A-Bear has donated more than $22 million and 1.5 million furry friends to charitable causes around the world. For more information, please visit http://www.buildabearfoundation.org.

About Build-A-Bear Workshop, Inc. (NYSE: BBW)

Build-A-Bear is a multi-generational global brand focused on its mission to “add a little more heart to life” appealing to a wide array of consumer groups who enjoy the personal expression in making their own “furry friends” to celebrate and commemorate life moments. Nearly 500 interactive brick-and-mortar retail locations operated through a variety of formats provide guests of all ages a hands-on entertaining experience, which often fosters a lasting and emotional brand connection. The company also offers engaging e-commerce/digital purchasing experiences on http://www.buildabear.com including its online “Bear-Builder”, the animated “Bear Builder 3D Workshop” and its age-gated adult-focused “Bear Cave.” In addition, extending its brand power beyond retail, Build-A-Bear Entertainment, a subsidiary of Build-A-Bear Workshop, Inc., is dedicated to creating engaging content for kids and adults that fulfills the company’s mission, while the company also offers products at wholesale and in non-plush consumer categories via licensing agreements with leading manufacturers. Build-A-Bear Workshop, Inc. (NYSE: BBW) posted total revenue of $411.5 million in fiscal 2021.

# # #

Media Contact:

Shriners Children’s, Marketing and Communications

Corporate Headquarters

Anthony Watts

ajwatts@shrinenet.org

(813)-220-8167

Shriners Children’s Greenville

Trana Downs

tpittam@shrinenet.org

‭(864) 350-6333‬

Share article on social media or email:

Pioneer in the Field of Reproductive Medicine Recognized for Lifetime Achievement


Dr. Yuzpe has been a shoulder to stand on, a mentor, and an inspiration to so many of us in the field of fertility,” says Dr. Hitkari, co-director and co-founder of Olive Fertility Centre

Olive Fertility Centre is proud to announce that Dr. Al Yuzpe, co-director and co-founder of Olive Fertility Centre, Chief Medical Officer for The Fertility Partners, and a pioneer in reproductive medicine, received the 2022 Lifetime Achievement Award at the 68th Canadian Fertility and Andrology Society (CFAS) Annual Meeting.

The Lifetime Achievement Award is a special recognition of an individual for extraordinary commitment and proven long-term contributions to the nonprofit CFAS and the field of reproductive science.

It would be difficult to overstate the impact that Dr. Yuzpe has had on the lives of thousands of individuals and couples in British Columbia, Canada and worldwide. He has been called the “grandfather of IVF in Canada” and is the recipient of numerous awards for his distinguished career in reproductive endocrinology and infertility and his dedication to women’s health. During his over 50-year career Dr Yuzpe has been internationally recognized for his pioneering work and has helped untold numbers of infertile couples realize their dream of having a family.

“And beyond his contribution to the advancement of fertility treatment and women’s health, Dr. Yuzpe has been a shoulder to stand on, a mentor, and an inspiration to so many of us in the field of fertility, not to mention a compassionate and beloved doctor to the thousands of individuals and couples he has helped to create a family,” says Dr. Jason Hitkari, co-director and co-founder of Olive Fertility Centre.

Dr. Yuzpe has contributed to many ground-breaking advancements that are not only the cornerstones of modern fertility treatment but have helped save the lives and improve the health of millions of women. Dr. Yuzpe is responsible for the development of an emergency contraceptive method using regularly available birth control pills, also referred to as the “Yuzpe method.”

He is renowned for his contribution to the development of laparoscopic surgery. During the 1970s and 1980s, Dr. Yuzpe helped to develop and refine the method by which surgeries could be done through small “keyhole” incisions, thereby reducing pain and recovery times for patients. The field of laparoscopy has now revolutionized medicine in Canada and internationally as minimally invasive surgery has become the norm in virtually every surgical specialty from fertility treatment to gynecology, to orthopedics, to general surgery.

Dr. Yuzpe is a leader in fertility treatment in Canada. When he first began his career there was little that medicine could offer infertile couples. Dr. Yuzpe has been instrumental in developing the cornerstone treatments and protocols which are now the standard for fertility treatment worldwide, including developing the fertility drugs, clomiphene citrate and human menopausal gonadotropins.

Early on, he recognized how in vitro fertilization (IVF) could revolutionize the treatment of infertility and how it had the potential to help millions of couples struggling to have a family. Because of his work with the Nobel Prize-winning scientists Dr. Robert Steptoe and Dr. Patrick Edwards, the U.K. physicians responsible for the world’s first IVF birth in 1978, Dr. Yuzpe was instrumental in bringing IVF to Canada, and in 1982 he founded one of the first IVF centers in Canada at the University of Western Ontario.

“Over the past few years, I have had the opportunity to develop a strong relationship with Dr. Al Yuzpe,” said CFAS Executive Director Dr. Goldi Gill. “Reflective of his knowledgeable and humble character, he is always willing to lend a helping hand to both me and the CFAS, an organization he has been an integral part of for so many years. I am thrilled that he is receiving this prestigious award, as it demonstrates his dedication to the CFAS, as well as the greater field of assisted reproductive technology (ART).”

“When I first began my career in obstetrics and gynecology in the 1970s, we didn’t have very much to offer those who suffered from infertility,” said Dr. Yuzpe. “Now there is so much we can do. I feel fortunate to have worked with so many great minds over the years and to have been a part of the growth of fertility medicine. Thank you CFAS for the honor. Together, we have achieved great things.”

Not only has Dr Yuzpe been a visionary in the field of infertility, he has led the way in making family building accessible to all. At a time when fertility treatment was only available to married couples in British Columbia, Dr. Yuzpe and co-founder Dr. Margo Fluker opened a clinic that they envisioned would be available to anyone who wished to create a family.

“When the original clinic we were part of was born in 1995, Al and his working partner vowed to make the clinic all-inclusive, in other words, welcoming and accessible to all those wanting to create a family, regardless of their gender, sexuality, and relationship status,” says Wendy Baker RN, Coordinator Donor Sperm Program, Olive Fertility.

“We have always held tremendous respect for Dr. Yuzpe’s decades of experience and tireless commitment to improving fertility medicine,” said Dr. Andrew Meikle, Founder and Chief Executive Officer of The Fertility Partners (TFP). “The CFAS Lifelong Achievement Award is a great honor and well deserved. I know the entire TFP network is beyond proud to consider him part of the team.”

Olive Fertility Centre olivefertility.com is one Canada’s leading fertility and prenatal diagnosis clinics, offering an award-winning IVF lab, personal care teams, and innovative programs including specialized genetic testing, egg freezing and prenatal NIPT testing.

Share article on social media or email:

Designer Suzy Levian Aligns New Pink Sapphire and Diamond Jewelry Collections with Breast Cancer Advocacy


Suzy Levian Sterling Silver Pink Sapphire and Diamond Accent Wrapped Heart Pendant

Breast Cancer is a battle no one should ever have to go through, and I wanted to create something that would help move us towards more solutions, while inspiring each other.

Born into a jewelry legacy, Suzy Levian was the youngest of five children, with an aptitude for illustrating intricate designs. Rendering sketches for the family business early on, she had her eye on entrepreneurship, envisioning a signature brand across multiple categories, with female empowerment as the cornerstone. A mother of six, Suzy Levian embraces the dualities of modern womanhood—from nurture and networking to beauty and efficiency, her collections balance wearable, useable, beautiful pieces, with embracing one’s inner power. This October, Suzy is partnering to support women diagnosed with breast cancer, through the Suzy Levian Breast Cancer Awareness Month Page on her website. Those shopping the new jewels will have a portion of the proceeds from each sale donated back to three research foundations: National Breast Cancer Foundation, Susan B. Komen Race for the Cure, and the Breast Cancer Research Foundation, offering an opportunity to give back while accessorizing, or to gift in solidarity.

The page features a selection of new pink and white jewels by Suzy Levian, with gemstones including: pink sapphire, diamond, morganite, cubic zirconia, pearl, and amethyst. Set in sterling silver, her Breast Cancer Awareness Collection is affordably priced, for woman to own and show camaraderie. As the most common cancer diagnosed in women, also occurring in men, breast cancer irreversibly changes lives. It is crucial to provide support for ongoing research and development.

Each Suzy Levian jewel features a signature hidden diamond within the band, symbolizing one’s inner strength. Meaningful for this collection, cancer warriors and advocates can wear a Suzy Levian Breast Cancer Awareness Collection jewel, recognizing the journey and inner strength to keep fighting, for oneself, and for loved ones.

“The process of going through hardship goes hand-in-hand with lifting others up,” says designer, Suzy Levian. “Breast Cancer is a battle no one should ever have to go through, and I wanted to create something that would help move us towards more solutions, while inspiring each other.”

To shop the Suzy Levian Breast Cancer Awareness Collection, visit https://suzylevian.com/collections/breast-cancer-awareness-month, call 516-918-9998 or email customerservice@suzylevian.com. For press inquiries, contact Pietra Communication at 212-913-9761 or email info@pietrapr.com.

About Suzy Levian

Suzy Levian is the youngest of the five children of Mr. A. LeVian, the founder of LeVian Corp. While working with her brothers at LeVian Corp., Suzy opened her own business, with the goal of empowering women through beautiful, affordable jewelry designs for all. Her signature collections are renowned for their breathtaking juxtaposition of gemstones and curves. Passionate and energizing, Suzy Levian creates provocative, elegant accessories catering to women invigorating their inner power.

Share article on social media or email:

La Vita Compounding is North County’s #1 pharmacy for 7 years!


“We want to thank our patients and practitioners for trusting us to compound their medications and selecting us as their number #1 pharmacy for the 7th year in a row!” stated Deb Hubers, Co-Founder.

La Vita partners with the nation’s leading functional medical providers in innovating personalized medications to treat their patient’s needs. La Vita has led functional medicine’s personalized medicine movement by formulating patented vitamin formulations and affiliating with EpigeneticsRx, a “one-stop digital destination for Precision Healthcare” with a network of over 2,500 practitioners focused on providing precise, predictive, personalized care.

Chris Givant, RPh and Co-Founder states, “our goal is to always provide the safest and highest quality compounding services within the industry. That is why we invest in PCAB Accreditation and appreciate the opportunity to help people live better longer.”

Click here to learn more

https://www.delmartimes.net/dmt-best-of-north-coast-htmlstory.html

About La Vita

La Vita Compounding Pharmacy prepares personalized medications for each patient formulated in conjunction with a medical practitioner. All formulations are prepared with care, quality, and safety, in various dosages using unique delivery systems. We offer a variety of combinations and customized formulations not found anywhere else. PCAB Accredited ® for sterile and non-sterile compounding, La Vita works with you and your practitioner to get you on the path to living, better, longer. For more information, contact Deb Hubers at mailto:Deb@lavitarx.com [Deb@lavitarx.com __title__ null], visit our website http://www.lavitarx.com or http://www.epigeneticsrx.com . Join us on Facebook, Twitter, LinkedIn

About The Coast News Group

The Coast News Group serves San Diego county’s north county communities and publishes the Del Mar Times, Carmel Valley News, Solana Beach Sun and Rancho Santa Fe Review. For more information, visit http://www.thecoastnews.com .

Share article on social media or email:

I’m Not Sorry – New study delves into the minds of people who refuse to apologize


Hate saying sorry even when you’ve done something wrong? Part of it is pride, but another factor might be underdeveloped emotional and social intelligence.

The moral compass of unapologetic people may not always point north, but their unwillingness to say sorry could also be linked to underdeveloped emotional and social intelligence.

Unrepentant people look at apologizing from the perspective of ‘If I say sorry, how will it make me look?’ rather than trying to understand how it would benefit the other person or the relationship.

History is filled with really lousy apologies. A well-known chef accused of unsavory conduct sent fans a half-hearted apology and a recipe for cinnamon rolls. An actor turned writer stole plotlines, and then when it became public, also plagiarized an apology. But what can be said of people who simply refuse to apologize at all, sincerely or not? A study by PsychTests.com looks into the personality, attitude, and behavior of people who stubbornly withhold their “mea culpa” even when they know they’ve done something wrong.

Analyzing data collected from 12,259 people who took the Emotional Intelligence Test, PsychTests’ researchers compared people who are willing to apologize after committing a transgression (“Apologizers”) and those who are not (“Defiers”).

Here’s what the results revealed:

DEFIERS ARE MORE LIKELY TO CROSS PERSONAL AND SOCIAL BOUNDARIES

  • 27% of Defiers don’t bother to consider the ethical consequences of their decisions (vs. 4% of Apologizers).
  • 25% think it’s a good idea to tell a depressed person to “toughen up” (vs. 11% of Apologizers).
  • 22% said they would rather be feared than loved (vs. 5% of Apologizers).
  • 16% said that they rarely, if ever, stick to their principles (vs. 6% of Apologizers).
  • 12% believe it is acceptable to tell a homeless person to get a job (vs. 3% of Apologizers).
  • 11% think it’s okay to offer unsolicited weight loss advice to an obese stranger (vs. 2% of Apologizers).

DEFIERS ARE WILLING TO COMMIT ACTS OF KINDNESS, BUT LESS SO THAN APOLOGIZERS

  • When looking at acts of kindness committed within the last few months, here’s how the two groups compared:
  • 69% of Defiers have given a pedestrian or another driver the right of way (compared to 97% of Apologizers).
  • 42% donated their time or money to charity (compared to 67% of Apologizers).
  • 74% held the door open for someone (compared to 95% of Apologizers).
  • 40% gave a homeless person food or money (compared to 52% of Apologizers).
  • Yet, Defiers’ kindness might sometimes come with catch, as 31% indicated that they want to be praised when they do something nice, compared to 17% of Apologizers.

DEFIERS TEND TO HAVE A MORE CYNICAL VIEW OF MORALITY AND PEOPLE

  • 20% think that cheating and lying are only wrong if a person gets caught (vs. 3% of Apologizers).
  • 34% are fine with using insincere flattery in order to get what they want from someone (vs. 22% of Apologizers).
  • 28% feel that dishonesty is necessary in order to get ahead in life (vs. 16% of Apologizers).
  • 29% believe that if an ignorant or naïve person is taken advantage of, it’s their own fault (vs. 12% of Apologizers).

DEFIERS ARE MORE LIKELY TO HAVE LOWER EMOTIONAL INTELLIGENCE THAN APOLOGIZERS

  • The Defier group’s average EQ score was 17 points lower than Apologizers’ score. Moreover, Defiers scored lower than the general population average by 11 points. They were also outscored by Apologizers on Self-esteem (10 points) and on Flexibility & Open-mindedness (23 points).

PSYCHTESTS’ STUDY ALSO INDICATED THAT:

  • 40% of Defiers are uncomfortable in emotionally charged situations (vs. 31% of Apologizers).
  • 34% find it hard to express their feelings (vs. 26% of Apologizers).
  • 28% insult themselves when they fail or make a mistake (vs. 19% of Apologizers).

“An unwillingness to apologize says a lot about a person’s character,” explains Dr. Ilona Jerabek, president of PsychTests. “A large part of it is pride; it burns us to have to give the other person the satisfaction of being right because we believe it will make us lose face and look foolish. However, the pattern we are seeing in our study is that it’s more than just a matter of ego. People who refuse to say sorry are not only less kind to their fellow human beings, they also seem to unapologetically commit faux pas that would make most people cringe. They scoff at the idea of a moral code by defying their own principles, and some of the Defiers actually scorn the victims of transgressions rather than the transgressors themselves. So, this sense of defiance and spite appears to run deep.”

“The question remains, what compels these people to withhold apologies? Well, based on our study, emotional and social intelligence, or a lack thereof, appear to play a major role. People with high EQ are empathetic, compassionate, and both socially and self-aware, which means they are able to put themselves in other people’s shoes and understand how their actions hurt others. Defiers certainly possess the capacity for empathy, but fail to expand their awareness to the consequences of their lack of remorse. This means that unrepentant people look at apologizing from the perspective of ‘If I say sorry, how will it make me look?’ rather than trying to understand how it would benefit the other person or the relationship.”

HERE ARE SOME TIPS ON HOW TO OFFER A GENUINE APOLOGY, INSTEAD OF A HALF-HEARTED “OK…SORRY” OR “I’M SORRY, BUT…”:

  • Say “I am sorry for…” or “I apologize for” and state exactly what the transgression was.
  • Acknowledge that you were wrong and use empathy to recognize how your transgression affected the other person.
  • Express remorse and own your mistake.
  • Make amends.
  • Commit to taking steps in order to prevent something similar from happening again.
  • Let it go.

What’s your EQ? Find out more about the Emotional Intelligence Test here: https://testyourself.psychtests.com/testid/3979

Professional users, such as HR managers, coaches, and therapists, can request a free demo for this or other assessments from ARCH Profile’s extensive battery: http://hrtests.archprofile.com/testdrive_gen_1

To learn more about psychological testing, download this free eBook: http://hrtests.archprofile.com/personality-tests-in-hr

About PsychTests AIM Inc.

PsychTests AIM Inc. originally appeared on the internet scene in 1996. Since its inception, it has become a pre-eminent provider of psychological assessment products and services to human resource personnel, therapists and coaches, academics, researchers and a host of other professionals around the world. PsychTests AIM Inc. staff is comprised of a dedicated team of psychologists, test developers, researchers, statisticians, writers, and artificial intelligence experts (see ARCHProfile.com).

Share article on social media or email:

Options Medical Weight Loss™ Clinic Announces Oak Lawn, IL Grand Opening


“Patients can expect a warm and inviting atmosphere when they walk into our new Oak Lawn clinic for the first time. Our staff is excited to meet you and assist you in reaching whatever your weight loss goal may be,” said Dr. Matthew Walker, CEO of Options Medical Weight Loss.

Options Medical Weight LossTM has announced that its newest location at 5116 W 95th St. Oak Lawn, Illinois is now open. The clinic serves the communities of Northbrook, Northfield, and Morton Grove and joins six other Chicagoland Options Medical Weight Loss clinics.

“Patients can expect a warm and inviting atmosphere when they walk into our new Oak Lawn clinic for the first time. Our staff is excited to meet you and assist you in reaching whatever your weight loss goal may be,” said Dr. Matthew Walker, CEO of Options Medical Weight Loss.

Options Medical Weight Loss is well-known for providing high-quality, individually tailored weight loss solutions that achieve patients’ weight goals through personalized clinical experiences that yield improved health outcomes. The new Oak Lawn Options Medical Weight Loss clinic adds an important resource to the Chicagoland community. “We know the choice to improve your life through weight loss can be tough. So we make it easier by opening accessible clinics in areas like Oak Lawn where people live and work,” Walker said. “Convenient, neighborhood locations provide quick access to assistance and supervision from our medical weight loss professionals. For people who are struggling to lose weight, it’s important that they have options to help them with their battle. Our one-of-a-kind system delivers customized programs to assist in taking off those stubborn final 10 pounds, or well over 100 pounds—or anything in between,” Walker emphasized.

Options Medical Weight Loss patients enjoy a highly personalized, caring weight loss experience. The new facility in Oak Lawn provides a specialized staff, who design custom-tailored programs for each individual weight loss patient.

Using the patient’s unique biomarkers and medical history, Options care team employs a wide variety of scientifically proven solutions to suit each patient’s specific needs. Each patient also receives a weekly one-on-one counseling session to keep them on track toward reaching their weight loss goal. “Our care team listens to each individual’s personal struggles, provide nurturing counsel and cheer on successes. We’re not a team of faceless whitecoats hidden away in a laboratory. When you join Options, you’re not just getting a care team— you’re getting a friend, a coach, and a fan. Every step of the way we lend the caring support that weight loss patients don’t find elsewhere,” Walker said.

As a leading weight loss clinic, Options Medical Weight Loss combines the benefits of medical prescriptions along with a range of personalized nutrition programs managed by certified professionals. Every aspect of care is customized to each patient’s medical history, weight loss goals, and any social obstacles they may face. “The essential components that are so often disjointed in the weight loss industry are the aid of medications and the customization of nutrition programs. We are committed to delivering both with perfection,” Walker said.

“Along with our other clinics in the Midwest, Florida, and the Southwest, our Oak Lawn location adds to our ongoing national expansion that is bringing us closer to realizing our vision of helping a million people lose weight before 2030,“ noted Walker. Options Medical Weight Loss attributes its aggressive growth to its proven success in helping people attain better health, mobility, and self-confidence through the personalized care of its dedicated weight loss professionals.

Options Medical Weight Loss always offers new patients a free in-person consultation to assess their medical history, current nutrition habits, lifestyle, and weight loss goals. Patients can start their journey by signing up on the web for a free consultation at:

https://optionsmedicalweightloss.com/get-your-free-consultatio

n/ Or by calling 888-405-LOSE (5673).

To learn more about the new Oak Lawn location, visit:

https://optionsmedicalweightloss.com/oak-lawn-illinois-weight-l

oss-clinic/ Or call: 708-398-3226.

Share article on social media or email:

CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma


Man in glasses inside a Roswell Park laboratory

Dr. Renier Brentjens, Deputy Director at Roswell Park Comprehensive Cancer Center

These results provide a rationale for not just infusing a single population of CAR T cells but using several populations that may be targeted to different proteins on the surface of the tumor cell.

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute and Roswell Park Comprehensive Cancer Center report in a new study published today by the New England Journal of Medicine.

The patients were treated at MSK during the clinical trial and the CAR T cell manufacturing was performed at the institution’s Cell Therapy Cell Engineering Facility (CTCEF).

“It’s a novel cellular-therapy approach for multiple myeloma that, in this first small study, demonstrated a strong response rate in patients, even those who were previously treated with other CAR T calls targeted to another antigen, BCMA,” says Renier Brentjens, MD, PhD, Deputy Director and the Katherine Anne Gioia Endowed Chair in Cancer Medicine at Roswell Park and a co-senior author on the study. “It’s a proof-of-principle study, but these results provide a rationale for not just infusing a single population of CAR T cells but using several populations that may be targeted to different proteins on the surface of the tumor cell.”

The therapy, a chimeric antigen receptor (CAR) T-cell therapy, sparked remissions in 70.6% of the 17 patients in the trial, all of whom had myeloma that had relapsed or was resistant to previous therapies, report the study authors. Many of the responders had relapsed after treatment with a previous generation of CAR T-cell therapies, which target a cell antigen known as BCMA. The findings have spurred the opening of a larger trial of the new therapy, which targets an antigen known as GPRC5D, in patients with myeloma.

“CAR T-cell therapy is one of the most promising ways to treat cancer,” says Sham Mailankody, MBBS, first author and principal investigator for the clinical trial at MSK. “While the clinical trial is still in early stages, we are encouraged by the results as post-treatment tests are showing that six participants had a complete response to the treatment and twelve of the patients are showing a measurable decline in their cancer.”

“CAR T-cell therapies targeting BCMA [the B cell maturation antigen] ¬— a protein prevalent on immune system B cells — have shown promise in advanced myeloma, but many patients relapse,” says Eric L. Smith, MD, PhD, of Dana-Farber, co-senior author of the study along with Dr. Brentjens. “We developed CAR T cells targeting an antigen that we identified — called G protein-coupled receptor, class C group 5 member D, or GPRC5D — which were effective in the laboratory against myeloma cells and in animal models of the disease, including those that no longer responded to BCMA-targeting CAR T cells. Our phase 1 study represents the first time this second-generation CAR T-cell therapy has been tested in patients.”

Like most CAR T-cell therapies, the one reported in this study, and developed at MSK, is custom-made for each patient. Millions of T cells are collected from the patient’s blood and equipped with a synthetic gene that lets them lock onto a specific protein on cells — in this case, the GPRC5D antigen. The genetically enhanced cells are then infused back into the patient, where they lead an attack on cells carrying the antigen.

“Our preclinical work showed GPRC5D to be an attractive target for a CAR T-cell therapy for multiple myeloma,” adds Dr. Smith. “We found it to be especially abundant on myeloma cells compared to normal tissue.”

The GPRC5D antigen is something of a mystery, as its role in normal cell life is unclear. Still, when researchers probed the surface of myeloma cells for proteins that were particularly plentiful, GPRC5D stood out.

The 17 patients in the phase 1 trial at MSK had undergone a median of six prior treatments for myeloma, including several who had received CAR T-cell therapy targeting BCMA. Four dose levels of the second-generation CAR T-cell therapy were tested.

The study showed the therapy to be generally safe, with side effects comparable to those associated with BCMA-directed CAR T-cell therapies. Fifteen of the participants experienced cytokine release syndrome (CRS), a common, temporary consequence of CAR T-cell treatment marked by systemic inflammation. In all cases but one (in a patient who received the highest dose tested) CRS was mild or moderate. At the highest dose level, two patients experienced toxicity in the cerebellum of the brain. No patients died from adverse events associated with the treatment.

Post-treatment tests showed that 12 participants, representing 70.6% of the whole group, responded to the treatment, showing a measurable decline in their cancer. Six had a complete response, an absence of detectable cancer. Two of the patients are still showing a response to the therapy, more than a year after they were treated.

“We are very grateful to our patients and caregivers who participated in this early trial and are continuing to explore additional clinical trials of GPRC5D directed CART cells in combination with other promising treatments to improve outcomes for patients with this disease,” adds Dr. Mailankody.

# # #

About Memorial Sloan Kettering Cancer Center (MSK):

As the world’s oldest and largest private cancer center, Memorial Sloan Kettering Cancer Center has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control, and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 53 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. http://www.mskcc.org.

About Dana-Farber Cancer Institute:

Dana-Farber Cancer Institute (https://www.dana-farber.org) is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.

We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 5 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials.

About Roswell Park:

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Eight & Sand Law And Paul Law Offices Win $22.8 Million Jury Verdict In Defamation Case Against Railroad CSX Transportation And Its Chief Medical Officer


CSX Railroad and its Chief Medical Officer Liable for Defamation

Judgment was entered today after a Greenup County, Kentucky jury found railroad CSX Transportation, Inc. and its Chief Medical Officer, Dr. Craig Heligman, liable for defamation and interference with the doctor-patient relationship in delivering a verdict of $22,815,000 to two chiropractors. The case, Daniel Carey et al. v. CSX Transportation, Inc. et al. was tried in Greenup Circuit Court, Commonwealth of Kentucky, Case No. 18-CI-00348.

Dr. Daniel Carey, II, D. C. and Dr. Shannon Johnson, D.C. brought suit after Dr. Heligman sent a letter to an agency of the federal government, three insurance companies, and to the Ohio and Kentucky state chiropractic boards accusing Dr. Carey and Dr. Johnson of fraudulently treating CSX employees in the Tri-state area of Kentucky, Ohio and West Virginia. CSX later refused to accept any medical documentation from Dr. Carey and Dr. Johnson on behalf of its employees.

The jury found that the accusations of Dr. Heligman and CSX were false and that they interfered with the relationship between Drs. Carey and Johnson and their patients. The evidence at trial further demonstrated that CSX sought to avoid its obligation to pay medical benefits to its employees who treated with the chiropractors and acted with fraud, oppression, malice, or gross negligence.

The jury found Dr. Heligman and CSX liable for punitive damages in the amount of $21.4 million in addition to over one million dollars in business losses and reputational harm to Dr. Carey and Dr. Johnson. It is believed to be the largest jury verdict in the history of Greenup County, Kentucky.

Dr. Carey and Dr. Johnson were represented by trial counsel Jeff Dingwall of Eight & Sand Law and Greg Paul of Paul Law Offices. Local counsel was Ken Reed of The Law Office of Kenneth R. Reed.

Share article on social media or email: